Sign Up to like & get recommendations! 1
Published in 2022 at "JAMA dermatology"
DOI: 10.1001/jamadermatol.2022.4639
Abstract: Importance The registered dose of dupilumab for adult patients with atopic dermatitis (AD) is 300 mg every other week. At present, it is unknown whether serum dupilumab levels are associated with treatment response or adverse… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of applied clinical medical physics"
DOI: 10.1002/acm2.13434
Abstract: OBJECTIVE To investigate the capability of computed tomography (CT) radiomic features to predict the therapeutic response and local control of the locoregional recurrence lymph node (LN) after curative esophagectomy by chemoradiotherapy. METHODS This retrospective study… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Brain and Behavior"
DOI: 10.1002/brb3.2625
Abstract: The dorsal striatum, comprised of the caudate and putamen, is implicated in the pathophysiology of psychosis spectrum disorders. Given the high concentration of dopamine receptors in the striatum, striatal dopamine imbalance is a likely cause… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Depression and Anxiety"
DOI: 10.1002/da.23061
Abstract: Although trauma‐focused cognitive behavioral therapy (TF‐CBT) is the frontline treatment for posttraumatic stress disorder (PTSD), at least one‐third of patients are treatment nonresponders. This study aimed to identify neural markers of treatment response, specifically the… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Human Brain Mapping"
DOI: 10.1002/hbm.25529
Abstract: The pathophysiology of major depressive disorder (MDD) has been explored to be highly associated with the dysfunctional integration of brain networks. It is therefore imperative to explore neuroimaging biomarkers to aid diagnosis and treatment. In… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Hematological Oncology"
DOI: 10.1002/hon.72_2631
Abstract: 360 SERUM BIOMARKERS ARE ASSOCIATED WITH TREATMENT RESPONSE IN RELAPSED MANTLE CELL LYMPHOMA L. Lokhande | V.K. Emruli | A. Kolstad | M. Hutchings | R. Räty | J.D. Rodrigues | M. Jerkeman | S.… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of Clinical Laboratory Analysis"
DOI: 10.1002/jcla.24650
Abstract: Mucosa‐associated lymphoid tissue lymphoma translocation protein 1 (MALT1) mediates the immunity and inflammatory response in multiple ways to be intimately involved in the progression of autoimmune diseases. This study intended to explore the linkage of… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Journal of Magnetic Resonance Imaging"
DOI: 10.1002/jmri.28659
Abstract: As the incidence of hepatocellular carcinoma (HCC) and subsequent treatments with liver‐directed therapies rise, the complexity of assessing lesion response has also increased. The Liver Imaging Reporting and Data Systems (LI‐RADS) treatment response algorithm (LI‐RADS… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Molecular Genetics & Genomic Medicine"
DOI: 10.1002/mgg3.1752
Abstract: Understanding how genetic polymorphisms are associated with the pathophysiology of major depressive disorder (MDD) may aid in diagnosis and the development of personalized treatment strategies. CNR1 is the gene coding Cannabinoid type 1 receptor which… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "NMR in Biomedicine"
DOI: 10.1002/nbm.4821
Abstract: To assess and compare the diagnostic performance of 3D amide proton‐transfer‐weighted (3D‐APTW) imaging, 3D pseudocontinuous arterial spin‐labeling (3D‐PcASL) imaging, and diffusion‐weighted imaging in distinguishing true progression (TP) from treatment response (TR) in posttreatment malignant glioma… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "NMR in biomedicine"
DOI: 10.1002/nbm.4932
Abstract: Non-Alcoholic Fatty Liver Disease (NAFLD) is the leading cause of chronic liver disease worldwide. Liver biopsy remains the gold-standard for diagnosis and staging of disease. There is a clinical need for non-invasive diagnostic tools for… read more here.